Aurobindo Pharma pays $139 mn to redeem FCCBs

Image
Press Trust of India New Delhi
Last Updated : Jan 20 2013 | 9:33 PM IST

Aurobindo Pharma today said it has paid $139.2 million (over Rs 600 crore) for the redemption of outstanding overseas bonds issued in 2006.

With the latest payout, the company has now paid an aggregate amount of $203.86 million for redemption of two tranches of foreign currency convertible bonds (FCCBs) issued in May, 2006, Aurobindo Pharma said in a filing to the Bombay Stock Exchange (BSE).

"Pursuant to this, all bonds issued by the company in May, 2006, have been extinguished in full and there are no outstanding as on date," it added.

After the repurchase and cancellation of FCCBs from time-to-time, the outstanding nominal value of FCCBs of $106.25 million has been paid in full at the redemption price of 146.285% of the principal amount on the maturity date, it said.

The company had issued FCCBs aggregating to $150 million in one tranche, dubbed Tranche A, on May 12, 2006.

The company has also paid $32.95 million for the redemption of FCCBs issued on May 17, 2006. The Hyderabad- based firm had issued FCCBs aggregating to $50 million in this second tranche, Tranche B.

"... The outstanding nominal value of FCCBs of $32.95 million has been paid in full at the redemption price of 146.991% of its principal amount on maturity date, May 17, 2011," the company said.

Shares of Aurobindo Pharma were being quoted at Rs 192.50 apiece on the BSE in late afternoon trade today, up 1.50% from their previous close.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 18 2011 | 2:09 PM IST

Next Story